Global Pain Relieving Drugs Market Worth $67.8bn in 2016

Wednesday 1 February 2017, Amsterdam

This new report, now available on ASDReports, Pain Relieving Drugs Market Forecast 2017-2027: Neuropathic Pain Relieving Drugs, Narcotic Pain Relieving Drugs, Non-Narcotic Pain Relieving Drugs, Anti-Arthritic Pain Relieving Drugs, Anti-Migraine Pain Relieving Drugs indicates that the global pain relieving drugs market is worth $67.8bn in 2016.

The global pain relieving drugs market is expected to grow at a CAGR of 2.1% from 2021-2027. The market is expected to grow from $67.8bn in 2016 to $75.2bn in 2027.

The lead analyst of the report said: “The pain relieving drug market has become a mainstay of the modern pharmaceutical industry providing people relief from pain caused by numerous diseases and conditions. Advances in modern technologies have help to provide the pain relieving drug market much room for significant revenue growth in the near future as innovation new drug candidates are developed. Though numerous blockbusters, pain relieving medications will face increased competition from generic erosion in the coming decade.”

The 308 page report contains 122 tables and 121 charts that add visual analysis in order to explain the developing trends within the Global Pain Relieving Drugs Market. Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the leading segments of this market: Neuropathic Pain Relieving Drugs, Narcotic Pain Relieving Drugs, Non-Narcotic Pain Relieving Drugs, Anti-Arthritic Pain Relieving Drugs, Anti-Migraine Pain Relieving Drugs and Others.

The key player also provides revenue forecasts for the period 2017-2027 for the leading drugs under each leading segment.

The 308 page report offers market forecasts and analysis for 12 leading national markets: US, Japan, Germany, France, UK, Spain, Italy, Russia, Brazil, India, China and the Rest of the World.